Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australian Medical Device Framework Takes Effect; Reuse Is On Horizon

This article was originally published in The Gray Sheet

Executive Summary

Sponsors of the 20% of CE-marked Class I, Class IIa and Class IIb devices randomly selected to undergo an audit by Australia's Therapeutic Goods Administration will pay additional fees under the country's new medical device framework, which took effect Oct. 4

You may also be interested in...



SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA

Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration

SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA

Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration

Device Modification Review Times Fall Behind In Canada, Australia, Japan

Manufacturers having difficulty defining "substantial change" when determining whether to submit product modification plans to regulatory authorities should formalize their internal decision-making processes, according to Guidant Regulatory Affairs Manager Gayle Johnson

Related Content

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel